Pearl River Capital’s Phibro Animal Health PAHC Stock Holding History

Pearl River Capital’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-100	Closed	-$3K	–	660
2018 Q4	$3K	Buy	+100	New	+$3.77K	0.01%	768

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Pearl River Capital's PAHC Position: Q1 2019 in Review

Pearl River Capital sold out of Phibro Animal Health (PAHC) in Q1 2019, closing a stake of 100 shares — an estimated $3K sold.

Pearl River Capital first reported a position in PAHC in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 176 funds tracked by Wall St. Rank hold PAHC as of Q1 2019.

Pearl River Capital reported no remaining Phibro Animal Health position as of Q1 2019 after selling out during the quarter.
Pearl River Capital sold 100 Phibro Animal Health shares in Q1 2019, an estimated $3K.
Pearl River Capital first reported a position in Phibro Animal Health in Q4 2018 and held it in 1 quarter.
Pearl River Capital's Phibro Animal Health position peaked at $3K in Q4 2018.
176 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2019.

Based on Pearl River Capital's 13F filing for Q1 2019, filed 2 May 2019.